Filing Details

Accession Number:
0001104659-17-058681
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-25 17:44:12
Reporting Period:
2017-09-21
Accepted Time:
2017-09-25 17:44:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1491576 Tesaro Inc. TSRO Pharmaceutical Preparations (2834) 272249687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653276 Jr. H. Martin Huber C/O Tesaro, Inc.
1000 Winter Street
Waltham MA 02451
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-21 1,250 $0.00 6,943 No 4 M Direct
Common Stock Disposition 2017-09-22 592 $118.60 6,351 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2017-09-21 1,250 $0.00 1,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,500 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of TESARO common stock.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of the restricted stock units.
  3. On September 21, 2015, the reporting person was granted 5,000 restricted stock units, vesting in in four equal annual installments beginning September 21, 2016.